BIOMAT Database Logo BIOMAT Database Logo

Role of the insulin receptor kinase activity in insulin action. 1988

M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Third Department of Internal Medicine, University of Tokyo, Japan.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017451 Receptors, Somatomedin Cell surface receptors that bind somatomedins and trigger intracellular changes which influence the behavior of cells. Studies have disclosed two types of receptors for this family of peptide hormones. The type I receptor is homologous to the insulin receptor and has tyrosine kinase activity. The type II receptor is identical to the mannose-6-phosphate receptor which is important in trafficking of lysosomal enzymes. Receptors, Insulin-Like Growth Factors,Somatomedin Receptors,Insulin-Like Growth Factor Receptor,Insulin-Like Growth Factor Receptors,Somatomedin Receptor,Insulin Like Growth Factor Receptor,Insulin Like Growth Factor Receptors,Receptor, Somatomedin,Receptors, Insulin Like Growth Factors
D066246 ErbB Receptors A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS. EGF Receptor,Epidermal Growth Factor Receptor,Epidermal Growth Factor Receptor Family Protein,Epidermal Growth Factor Receptor Protein-Tyrosine Kinase,ErbB Receptor,HER Family Receptor,Receptor, EGF,Receptor, Epidermal Growth Factor,Receptor, TGF-alpha,Receptor, Transforming-Growth Factor alpha,Receptor, Urogastrone,Receptors, Epidermal Growth Factor-Urogastrone,TGF-alpha Receptor,Transforming Growth Factor alpha Receptor,Urogastrone Receptor,c-erbB-1 Protein,erbB-1 Proto-Oncogene Protein,EGF Receptors,Epidermal Growth Factor Receptor Family Proteins,Epidermal Growth Factor Receptor Kinase,HER Family Receptors,Proto-oncogene c-ErbB-1 Protein,Receptor Tyrosine-protein Kinase erbB-1,Receptor, ErbB-1,Receptors, Epidermal Growth Factor,Epidermal Growth Factor Receptor Protein Tyrosine Kinase,ErbB-1 Receptor,Family Receptor, HER,Family Receptors, HER,Proto oncogene c ErbB 1 Protein,Proto-Oncogene Protein, erbB-1,Receptor Tyrosine protein Kinase erbB 1,Receptor, ErbB,Receptor, ErbB 1,Receptor, HER Family,Receptor, TGF alpha,Receptor, Transforming Growth Factor alpha,Receptors, EGF,Receptors, Epidermal Growth Factor Urogastrone,Receptors, ErbB,Receptors, HER Family,c erbB 1 Protein,c-ErbB-1 Protein, Proto-oncogene,erbB 1 Proto Oncogene Protein

Related Publications

M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Insulin receptor: tyrosine kinase activity and insulin action.
January 1989, Reproduction, nutrition, development,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Antiphosphotyrosine antibodies modulate insulin receptor kinase activity and insulin action.
January 1989, Cellular signalling,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Rat insulin-receptor kinase activity correlates with in vivo insulin action.
January 1989, Diabetes,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
The role of receptor kinase activity and the NPEY960 motif in insulin-accelerated receptor-mediated insulin internalization.
January 1996, Journal of receptor and signal transduction research,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
The role of receptor kinase in insulin action and the effects of insulin on human hepatoma cells.
February 1990, Clinical biochemistry,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
The role of protein kinase C in insulin action.
March 1992, Cellular signalling,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
The role of PI 3-kinase in insulin action.
December 1998, Biochimica et biophysica acta,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Intrinsic kinase activity of the insulin receptor.
January 1990, The International journal of biochemistry,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Protein kinase activity of the insulin receptor.
April 1986, The Biochemical journal,
M Kasuga, and T Izumi, and K Tobe, and T Kadowaki, and K Momomura, and S Takayama-Hasumi, and O Koshio, and Y Tashiro-Hashimoto, and Y Akanuma, and F Takaku
Does the insulin-mimetic action of vanadate involve insulin receptor kinase?
November 1993, Molecular and cellular biochemistry,
Copied contents to your clipboard!